Literature DB >> 18332157

No apparent local effect of insulin on microdialysis continuous glucose- monitoring measurements.

Jeroen Hermanides1, Iris M Wentholt, Augustinus A Hart, Joost B Hoekstra, J Hans DeVries.   

Abstract

OBJECTIVE: Data investigating the possible disturbing influence of insulin in the vicinity of continuous glucose monitoring (CGM) is lacking. We investigated the hypothesis that high local insulin concentrations would interfere with sensor readings. RESEARCH DESIGN AND METHODS: Two microdialysis sensors were inserted in the periumbilical region of 10 continuous subcutaneous insulin infusion (CSII)-treated type 1 patients. A test sensor was inserted as close as possible to the insulin catheter and compared with a control sensor. Glucose peak and nadir were induced. Horizontal and vertical shifts were assessed using curve fitting, and mean absolute difference (MAD) between paired blood and sensor values were calculated.
RESULTS: Curve fitting showed no significant differences between the two sensors. MAD +/- SD was 8.50 +/- 3.47% for the test sensor and 9.21 +/- 3.17% for the control sensor, P = 0.72.
CONCLUSIONS: Microdialysis CGM can be accurately performed in the proximity of CSII systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18332157     DOI: 10.2337/dc08-0145

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  AP@home: a novel European approach to bring the artificial pancreas home.

Authors:  Lutz Heinemann; Carsten Benesch; J Hans DeVries
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 2.  Moving Toward a Unified Platform for Insulin Delivery and Sensing of Inputs Relevant to an Artificial Pancreas.

Authors:  Anneke Graf; Sybil A McAuley; Catriona Sims; Johanna Ulloa; Alicia J Jenkins; Gayane Voskanyan; David N O'Neal
Journal:  J Diabetes Sci Technol       Date:  2016-12-13

3.  Periodic extraction of interstitial fluid from the site of subcutaneous insulin infusion for the measurement of glucose: a novel single-port technique for the treatment of type 1 diabetes patients.

Authors:  Werner Regittnig; Stefan Lindpointner; Stefan Korsatko; Dina Tutkur; Manfred Bodenlenz; Thomas R Pieber
Journal:  Diabetes Technol Ther       Date:  2012-11-05       Impact factor: 6.118

4.  Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set.

Authors:  David N O'Neal; Sumona Adhya; Alicia Jenkins; Glenn Ward; John B Welsh; Gayane Voskanyan
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

Review 5.  Can glucose be monitored accurately at the site of subcutaneous insulin delivery?

Authors:  W Kenneth Ward; Jessica R Castle; Peter G Jacobs; Robert S Cargill
Journal:  J Diabetes Sci Technol       Date:  2014-02-18

6.  An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation.

Authors:  W Kenneth Ward; Gabriel Heinrich; Matthew Breen; Sheila Benware; Nicole Vollum; Kristin Morris; Chad Knutsen; Joseph D Kowalski; Scott Campbell; Jerry Biehler; Mark S Vreeke; Scott M Vanderwerf; Jessica R Castle; Robert S Cargill
Journal:  Diabetes Technol Ther       Date:  2017-02-21       Impact factor: 6.118

7.  Measuring glucose at the site of insulin delivery with a redox-mediated sensor.

Authors:  Peter G Jacobs; Nichole S Tyler; Scott M Vanderwerf; Clara Mosquera-Lopez; Thomas Seidl; Robert Cargill; Deborah Branigan; Katrina Ramsey; Kristin Morris; Sheila Benware; W Kenneth Ward; Jessica R Castle
Journal:  Biosens Bioelectron       Date:  2020-04-29       Impact factor: 12.545

8.  Glucose levels at the site of subcutaneous insulin administration and their relationship to plasma levels.

Authors:  Stefan Lindpointner; Stefan Korsatko; Gerd Köhler; Hans Köhler; Roland Schaller; Lukas Schaupp; Martin Ellmerer; Thomas R Pieber; Werner Regittnig
Journal:  Diabetes Care       Date:  2010-01-22       Impact factor: 17.152

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.